Index Entries

Elisabeth O’Regan, Lampros Spiliopoulos, Ingrid Bech Svalgaard, Nete Munk Nielsen, Anna Irene Vedel Sørensen, Peter Bager, Poul Videbech, Steen Ethelberg, Anders Koch, and Anders Hviid
October 7, 2024
JAMA Network Open
Statens Serum Institut (Denmark)

"Abstract

Design, Setting, and Participants: In this cohort study, Danish residents aged 15 years and older were invited to participate in the EFTER-COVID survey, which used repeated, self-reported online questionnaires that collected information on fatigue (Fatigue Assessment Scale) and postexertional malaise [PEM] scores (DePaul Symptom Questionnaire) after individuals’ index SARS-CoV-2 polymerase chain reaction test... 

Results: Of a total of 50 115 participants ... 25 249 were test positive and 24 866 were test negative. Most participants were vaccinated with at least 2 doses (21 164 test-negative participants [85.1%] and 22 120 test-positive participants [87.6%]) before their SARS-CoV-2 index test and fatigue reporting. In the period 2 to 18 months after testing, SARS-CoV-2 infection was associated with a small but significant 3% increase in self-reported fatigue scores ... and higher odds of self-reported postexertional malaise (odds ratio, 2.04; 95% CI, 1.81-2.30), compared with test-negative participants. In the same period, hospitalization with SARS-CoV-2 increased fatigue scores by 23% (SR, 1.23; 95% CI, 1.20-1.26) compared with test-negative participants...

Results

Study Population

... For test-positive participants, the prevalence of severe fatigue (1102 participants [7.6%]), substantial fatigue (5554 participants [38.5%]), and PEM (4174 participants [28.9%]) was highest at the 2-month follow-up point and generally decreased over time. At the 18-month follow-up, the prevalence of severe fatigue was 5.9% (474 participants), that of substantial fatigue was 33.1% (2659 participants), and that of PEM was 25.1% (2014 participants)."

document
adverse events,COVID-19,long COVID,vaccines